PRAECIS PHARMACEUTICALS INC receives FDA approval for Plenaxis
...PRAECIS PRAECIS PHARMACEUTICALS INCORPORATED is a biotechnology company focused on the discovery and development of innovative therapies to address unmet medical needs. In addition to its approval in the United States, PRAECIS has also initiated the regulatory review process for Plenaxis TM in the European Unio...First US tuberculosis vaccine trial in 60 years begins
... will be conducted in the United States by Seattle biotechnology company Corixa and GlaxoSmithKline Biologicals, a vaccine manufacturer headquartered in Belgium. "This is the first recombinant tuberculosis vaccine to reach human trials in the United States," says NIAID Director Anthony S. Fauci, M.D. "Indeed, this...Rensselaer researcher receives $2.1 million grant to develop treatment for anthrax
... is part of Rensselaer's overall effort to advance biotechnology discoveries for the benefit of public health, the environment, homeland security, bioterrorism, economic development locally and globally....Survey shows impact of psoriasis is more than skin deep
... is supported by Genentech. Genentech is a leading biotechnology company that discovers, develops, manufactures and...medical needs. Seventeen of the currently approved biotechnology products originated from or are based on Genentech science. Genentech manufactures and commercialize...Targeting cell fusion as possible way to repair organs, deliver cancer vaccines
... therapeutic ends," says Dr. Russell. "It offers a biotechnology platform that provides a way to choose and direct the agents of fusion by getting tumor cells to fuse with dendritic cells -- one cell type in the immune system. The result is biofusion that prompts the immune system to attack the tumor. "This is im...Center for Health Law and Policy presents symposium on developing innovative therapies
...ressant drug. Another recent article reported that biotechnology companies are moving away from the risky business of developing new technologies and instead are licensing drugs that are already on the market, in part because of complex federal regulations. These stories underscore the tension between two equally ...2004 Research in Prosthodontics/Implants Award to Nishimura
...ering of normal and functional tissue of the face, biotechnology application to wound healing, and human genome bio-informatics and silico-molecular modeling. Supported by Procter & Gamble Denture Care and given in memory of Willard J Tarbet, this award was established to encourage and give recognition to outstan...Study finds few new antibiotics are in the pipeline
...programs of the world's largest pharmaceutical and biotechnology companies, by looking at the companies' websites and 2002 annual reports. They found that FDA approvals of new antibiotics declined 56 percent during the past 20 years (1998-2002 versus 1983-1987). Looking to the future, the researchers found only si...New type of anthrax vaccine moves into larger-scale trial at Saint Louis University
...versity. VaxGen Inc., a California-based biotechnology company, is sponsoring the vaccine development and study through an accelerated program funded by the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health. Dr. Gorse said a total of 480 healt...Preliminary results are promising in Alzheimer's gene therapy trial
...-wide licensee is Ceregene, Inc. a San Diego-based biotechnology company focused on the development and commercialization of gene therapies for neurological disorders including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS). Ceregene was launched in January 2001 and is a majority-...Mayo researchers invent targeted imaging probe to aid early Alzheimer's diagnosis
...contrast agent for use in Alzheimer's disease, the biotechnology reported here may provide a general procedure for enhancing delivery of other diagnostic and therapeutic proteins across the blood-brain barrier for other neurodegenerative disorders as well."...Hebrew University one of 25 institutions involved in new European Vascular Genomics Network
...by uniting 25 basic and clinical institutions, two biotechnology companies and one management company from ten EU member or associated states. EVGN is one of the networks of excellence funded by the European Union within its 6th Framework Program -- Life Science, Genomics and Biotechnology for Health -- aimed at ...Serono receives FDA approval for Gonal-f RFF Pen to treat infertility
...kland, MA, is the US affiliate of Serono, a global biotechnology leader, headquartered in Geneva, Switzerland. Serono has seven recombinant products, Rebif (interferon beta-1a), Gonal-f (follitropin alfa for injection), Luveris (lutropin alfa), Ovidrel PreFilled Syringe/Ovitrelle (choriogonadotropin alfa injection...Super sprouts could help reduce cancer risk
..., Stepping Stones To Success, a major all Ireland biotechnology conference being held at the University's of Ulste...portunities opening up for the island's burgeoning biotechnology sector....Chemists honor 'Heroes' for biotechnology achievements in health
...drugs, vaccines, nutritional supplements and other biotechnology products based on chemistry or biochemistry. Multidisciplinary teams from 3M, QLT Inc., Schering-Plough Corp. and Wyeth Pharmaceuticals have been recognized by the ACS for developing innovative therapies for eye disease, skin cancer, leukemia, genita...Donald W. Reynolds Foundation awards UT Southwestern $12 million to continue Dallas Heart Study
... of individuals from Dallas County, to develop new biotechnology and to establish a novel training program for scientists-physicians. Major discoveries by center-affiliated investigators since 1999 include: Identification of key chemical signals that change a stem cell into a heart cell, which may lead to the a...Rice bioengineer named to Technology Review's TR100
...e of technology and business in industries such as biotechnology and medicine, computing, and nanotechnology. "In two short years at Rice, Rebekah Drezek has established a reputation among both faculty and students as an outstanding scholar and teacher," said Rice President David Leebron. "Her application of nanot...Growing epidemic of wet AMD ushers in new era in treatment of the disease
... addition to vision rehabilitation, innovations in biotechnology have the potential to fill the large unmet medical need by offering new treatments to wet AMD patients. Hope on the Horizon: Anti-VEGF, Anti-Angiogenic and Angiostatic Treatments Dr. Carmen A. Puliafito...Journal of Alzheimer's disease to publish ISOA Catalyst Conference
... disease represents a major challenge to academic, biotechnology and pharmaceutical scientists. Current therapies for the neurodegenerative diseases provide effective symptomatic relief, particularly in early stages of disease. However, there are too few, if any therapies that affect the underlying disease proce...JAMA editors call for major restructuring of postmarketing surveillance system
...ent of influence from the pharmaceutical industry, biotechnology firms, and medical device manufacturers." "The postmarketing surveillance system requires a long overdue major restructuring. Until that occurs as indicated by the articles in this issue of JAMA, as epitomized by recent evidence of serious harms fr...